Research takes a lot of time and developing vaccines takes years. Operation Warp Speed did show us that speeding up slow research is possible. Streamlining the process is important because there are a lot of approvals and hoops to jump through. However, the risks to life were greater if we didn't develop a vaccine. It was necessary to accept some risk in the process. Yet it does tell us a little about research and our ability to speed up the process.
Can we apply those ideas to universities for national innovation?
The same concept couple be applied to innovation industry research. Things take time so sometimes good ideas can't be rushed to an "aha moment". However, science does follow a process of learning, integrating, and applying knowledge. Thus, innovation has something to do with the amount of time we spend in research. We might be able to better utilize our human capital.
Online universities do have options to create more innovation in the market that impact large swaths of industry. For example, a new biodegradable plastic that can be made at a competitive price might not only make billions but also help the planet. One complaint of universities is they don't often take new knowledge and apply it quickly to industry in a way that leads to innovation. We will need our universities to invent great ideas (online and campus based) and novel solutions to be used in the market.
Streamlining research that isn't risky to human life and encouraging universities engage in more applied research can be helpful for national R&D and innovation. Encouraging industries to help universities by investing in particular researcher on a larger scale might help some schools that are struggling. Save schools while maximizing national research. Just an idea that isn't necessarily vetted.
You can Read the Release HERE
President Trump Is Leading a Once-in-a-Generation Effort to Ensure Americans Have Access to a COVID-19 Vaccine
Vaccines are coming along really well. Likewise therapeutics. Moving faster than anticipated.
DEVELOPING EFFECTIVE VACCINES: President Donald J. Trump is harnessing the full power of the public and private sectors to deliver a safe and effective vaccine as soon as possible.
- The President is using all available means to ensure safe vaccines, therapeutics, and diagnostics are developed, manufactured, and distributed in unprecedented time and scale in response to COVID-19.
- Earlier this year, President Trump launched Operation Warp Speed, a groundbreaking partnership between the Federal Government, scientific community, and private sector to develop and deliver vaccines in record time.
- Operation Warp Speed’s goal is to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021.
- The Administration has made large investments in multiple vaccine candidates to provide financial infrastructure for mass manufacturing, in parallel with late-stage clinical trials.
- Operation Warp Speed is directing a colossal industrial mobilization to ensure the rapid delivery of an eventual safe vaccine.
SEEING TREMENDOUS PROGRESS: The President’s strategy for safely expediting vaccine development is already achieving incredible results.
- There has been promising early data from clinical trials and manufacturing is ramping up as candidates go through late-stage trials.
- Operation Warp Speed has invested in more than five vaccines and teamed up with multiple pharmaceutical companies to safely produce as many effective vaccines as possible.
- A number of vaccine candidates have shown promising early clinical results and are either in or starting Phase 3 clinical trials, including AstraZeneca, Moderna, and Pfizer.
- Several vaccine candidates are using the National Institutes of Health (NIH) clinical trial network to help enroll individuals into the clinical trials.
UNLEASHING AMERICAN INGENUITY: President Trump has unleashed the power of American innovation in order to fight the invisible enemy.
- The Trump Administration is using the whole of our Nation’s scientific genius to help combat COVID-19.
- The Food and Drug Administration (FDA) has authorized more than 185 tests under emergency authorities, including more than 150 molecular tests and 30 antibody tests.
- The FDA launched its Coronavirus Treatment Acceleration Program to facilitate new treatments for COVID-19 patients as quickly as possible.
- A number of promising therapies for COVID-19, like Remdesivir, have been identified and are already in use.
No comments:
Post a Comment